Myelodysplastic Syndromes Treatment News and Information

What are Myelodysplastic Syndromes? (Definition)

According to the National Cancer Institute, Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells.

The different types of myelodysplastic syndromes are diagnosed based on certain changes in the blood cells and bone marrow. Signs and symptoms of a myelodysplastic syndrome include shortness of breath and feeling tired.

See below for updated news and information regarding Myelodysplastic Syndromes including new medical research, treatment options and advancements. 

Latest Myelodysplastic Syndromes Treatment News and Research

Myelodysplastic Syndrome Treatment Research: Possible Treatment Targets Found for Pre-Malignant Bone Marrow Disorders

(SOURCE: CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER) - Cincinnati Children’s researchers report in Nature Immunology a new mechanism that controls blood cell function and several possible molecular targets for treating myelodysplasia syndromes (MDS) – a group of pre-malignant disorders in which bone marrow does not produce enough healthy blood cells. MDS can lead to acute myeloid leukemia (AML), a fast-spreading blood cancer that ...
Read More

Myelodysplastic Syndromes Research: Genetic classification offers guide to stem cell transplantation for patients with myelodysplastic syndrome

(SOURCE: Dana-Farber Cancer Institute) - A blood test can indicate whether some patients with myelodysplastic syndrome (MDS) are likely to benefit from a stem cell transplant and, if so, whether the transplant should involve high or moderate doses of chemotherapy and/or radiation therapy. The findings are according to study results to be presented by Dana-Farber Cancer Institute investigators at the 58th annual ...
Read More